டேவிட் எபஸ்வோர்த் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டேவிட் எபஸ்வோர்த். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டேவிட் எபஸ்வோர்த் Today - Breaking & Trending Today

SYNLAB delivers record growth in Q1 2021


SYNLAB delivers record growth in Q1 2021
Search jobs
DGAP-News: SYNLAB AG
/ Key word(s): Quarter Results
12.05.2021 / 07:30
SYNLAB delivers record growth in Q1 2021
- Nearly doubling revenue (+96%) in Q1 21 at EUR 938 million
- Strong SARS-CoV-2 testing volumes in Q1 21, above Q4 20
- Sustained underlying organic growth
- Adjusted EBITDA multiplied by 3.8x at EUR 324 million, margin showing strong volume leverage
- Record unlevered FCF of EUR 182 million driving major leverage ratio reduction at 2.3x, pre-IPO
- M&A activity resuming, with 10 acquisitions completed year-to-date (~EUR 44 million of EV)
- Successful IPO, with EUR 400 million raised to further reduce leverage ....

United Kingdom , City Of , Northern Region , Mark Reinhard , David Ebsworth , Carolin Amann , Mathieu Floreani , Sami Badarani , International Financial Reporting Standards , Frankfurt Stock Exchange , Hungarian Olympic Committee , Distribution Services , Quarter Results , Frankfurt Stock , South East London , Net Promoter Score , Enterprise Value , Supervisory Board , North Europe , Corporate News , Regulatory Announcements , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , வடக்கு பகுதி , டேவிட் எபஸ்வோர்த் , கரோலின் அமன் ,

SYNLAB sets price range for its planned IPO at EUR 18.00 to EUR 23.00 per share


Disclaimer
This release is not for distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada or Japan. It does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States, Australia, Canada or Japan. The shares mentioned herein have not been, and will not be, registered under the US Securities Act of 1933, as amended (the Securities Act ). The shares may not be offered or sold in the United States, except pursuant to an exemption from the registration requirements of the Securities Act. There will be no public offer of shares of SYNLAB AG (the Company ) in the United States. ....

United States , District Of Columbia , United Kingdom , Iris Schopper , Marc Welters , Peter Catterall , Anastasya Molodykh , Ute Hasholzner , Barbara Lambert , David Ebsworth , Finanzdienstleistungsaufsicht Bafin , Mathieu Floreani , Stefan Graf , Rene Schmidt Ferroud , Banque Pictet Cie , Bartl Wimmer , Karin Bierstedt , German Federal Financial Supervisory Authority Bafin , Dusseldorf Stock Exchange , Goldman Sachs , Virtx Exchange , Hanover Stock Exchange , Commission Delegated Directive , European Parliament , Chix Exchange , Financial Services ,